Symptoms of social anxiety disorder and major depressive disorder: A network perspective

被引:30
|
作者
Langer, Julia K. [1 ,3 ]
Tonge, Natasha A. [1 ,4 ]
Piccirillo, Marilyn [1 ,4 ]
Rodebaugh, Thomas L. [1 ,4 ]
Thompson, Renee J. [1 ,4 ]
Gotlib, Ian H. [2 ,5 ]
机构
[1] Washington Univ, 1 Brookings Dr, St Louis, MO 63130 USA
[2] Stanford Univ, 450 Serra Mall, Stanford, CA 94305 USA
[3] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA
[4] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63130 USA
[5] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA
关键词
Social anxiety disorder; Treatment; Depression; Assessment; Diagnosis; Anxiety disorders; CROSS-SECTIONAL ANALYSES; DSM-IV DISORDERS; MOOD DISORDERS; COMORBIDITY; PREVALENCE; INVENTORY; LIFETIME; PHOBIA; DIMENSIONS; RISK;
D O I
10.1016/j.jad.2018.09.078
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: We used network analyses to examine symptoms that may play a role in the co-occurrence of social anxiety disorder (SAD) and major depressive disorder (MDD). Whereas latent variable models examine relations among latent constructs, network analyses have the advantage of characterizing direct relations among the symptoms themselves. Method: We conducted network modeling on symptoms of social anxiety and depression in a clinical sample of 130 women who met criteria for SAD, MDD, both disorders, or had no lifetime history of mental illness. Results: In the resulting network, the core symptoms of social fear and depressed mood appeared at opposite ends of the network and were weakly related; so-called "bridges" between these symptoms appeared to occur via intervening variables. In particular, the worthless variable appeared to play a central role in the network. Limitations: Because our data were cross-sectional, we are unable to draw conclusions about the direction of these effects or whether these variables are related to each other prospectively. Conclusions: Continued testing of these pathways using longitudinal data will help facilitate the development of more effective clinical interventions for these disorders.
引用
收藏
页码:531 / 538
页数:8
相关论文
共 50 条
  • [31] Does comorbid Social Anxiety Disorder impact the clinical presentation of principal Major Depressive Disorder?
    Dalrymple, Kristy L.
    Zimmerman, Mark
    JOURNAL OF AFFECTIVE DISORDERS, 2007, 100 (1-3) : 241 - 247
  • [32] Genetic association of the oxytocin receptor genes with panic, major depressive disorder, and social anxiety disorder
    Onodera, Mayuko
    Ishitobi, Yoshinobu
    Tanaka, Yoshihiro
    Aizawa, Sayoko
    Masuda, Koji
    Inoue, Ayako
    Oshita, Harumi
    Okamoto, Kana
    Kawashima, Chiwa
    Nakanishi, Mari
    Hirakawa, Hirofumi
    Ninomiya, Taiga
    Maruyama, Yoshihiro
    Kanehisa, Masayuki
    Higuma, Haruka
    Akiyoshi, Jotaro
    PSYCHIATRIC GENETICS, 2015, 25 (05) : 212 - 212
  • [33] Exploring the clinical characteristics and etiological factors of comorbid major depressive disorder and social anxiety disorder
    Berkol, Tonguc Demir
    Unal, Ipek Ozonder
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (06): : 1136 - 1145
  • [34] Psychiatric comorbidities and emotional intelligence in internet gaming disorder: Attention deficit hyperactivity disorder, major depressive disorder, generalized anxiety disorder, and social anxiety disorder
    Ko, Chih-Hung
    Liu, Tai-Ling
    Wu, Hung-Chi
    Yeh, Yi-Chun
    Tsai, Wen-Xiang
    Yen, Ju-Yu
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (11) : 352 - 354
  • [35] Network Analysis of Behavioral Activation/ Inhibition Systems and Brain Volume in Individuals With and Without Major Depressive Disorder or Social Anxiety Disorder
    Liu, Qimin
    Davey, Delaney
    Jimmy, Jagan
    Ajilore, Olusola
    Klumpp, Heide
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2024, 9 (06) : 551 - 560
  • [36] Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications
    Malcolm Hopwood
    Neurology and Therapy, 2023, 12 : 5 - 12
  • [37] Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder
    Papakostas, George I.
    McGrath, Patrick
    Stewart, Jonathan
    Charles, Dana
    Chen, Ying
    Mischoulon, David
    Dording, Christina
    Fava, Maurizio
    PSYCHIATRY RESEARCH, 2008, 161 (01) : 116 - 120
  • [38] Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
    Davis, Lori L.
    Ota, Ai
    Perry, Pamela
    Tsuneyoshi, Kana
    Weiller, Emmanuelle
    Baker, Ross A.
    BRAIN AND BEHAVIOR, 2016, 6 (10):
  • [39] The role of leptin in indirectly mediating "somatic anxiety" symptoms in major depressive disorder
    Zhu, Yue
    Wei, Yange
    Duan, Jia
    Li, Jianing
    Zhang, Ran
    Sun, Jiaze
    Wang, Pengshuo
    Liu, Zhuang
    Lv, Jing
    Wei, Shengnan
    Jiang, Xiaowei
    Wang, Fei
    Tang, Yanqing
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [40] EFFICACY OF THE ANTIDEPRESSANT AGOMELATINE FOR THE ANXIETY SYMPTOMS OF DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Stein, D. J.
    Castle, D. J.
    Kennedy, S. H.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 : 31 - 32